Ryman Healthcare Ltd
OTC:RYHTY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ryman Healthcare Ltd
OTC:RYHTY
|
NZ |
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
Daiwabo Holdings Co Ltd
TSE:3107
|
JP |
|
Powszechna Kasa Oszczednosci Bank Polski SA
LSE:0FMO
|
PL |
|
H
|
Honeywell International Inc
LSE:HON
|
US |
Wall St Price Targets
RYHTY Price Targets Summary
Ryman Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
RYHTY is 8.64 USD with a low forecast of 7.52 USD and a high forecast of 10.79 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYHTY's stock price target?
Price Target
8.64
USD
According to Wall Street analysts, the average 1-year price target for
RYHTY is 8.64 USD with a low forecast of 7.52 USD and a high forecast of 10.79 USD.
What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 9%.